Press Release: Celularity Expands Advanced Biomaterial Product Commercial Portfolio With Acquisition of Rebound(TM) Product From Sequence LifeScience, Inc.
Press Release: Celularity Expands Advanced Biomaterial Product Commercial Portfolio With Acquisition of Rebound(TM) Product From Sequence LifeScience, Inc.
新聞發佈：Celularity通過從Sequence LifeScience, Inc.收購Rebound(TM)產品，擴展了愛文思控股的先進生物材料產品商業組合。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間